Alterity Therapeutics Lim... (ATHE)
NASDAQ: ATHE
· Real-Time Price · USD
5.17
-0.06 (-1.15%)
At close: Aug 15, 2025, 3:59 PM
5.20
0.58%
After-hours: Aug 15, 2025, 06:47 PM EDT
Alterity Therapeutics Cash Flow Statement
Financials in AUD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 |
Net Income | -3.59M | -3.59M | -12.62M | n/a | n/a | n/a | n/a | n/a | -8.03M | -6.26M | -6.58M | n/a | -8.56M |
Depreciation & Amortization | n/a | 36.3K | n/a | n/a | n/a | n/a | n/a | n/a | 50K | 22.68K | 31.54K | n/a | 35.63K |
Stock-Based Compensation | 560.63K | 560.63K | 284.83K | n/a | n/a | n/a | n/a | n/a | 627.22K | 630.82K | 875.3K | n/a | 1.58M |
Other Working Capital | -1M | 1.1M | 1.2M | n/a | n/a | n/a | n/a | n/a | 866.75K | 32.05K | -425.34K | n/a | 291.6K |
Other Non-Cash Items | -149.03K | -185.32K | 1.08M | n/a | -4.49M | n/a | -10.11M | n/a | 3.26M | -4.43M | -1.22M | -10M | 4.3M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.05M | 6.24M | -2.29M | n/a | 169.2K |
Change in Working Capital | -1M | -1M | 3.14M | n/a | n/a | n/a | n/a | n/a | -2.12M | 3.54M | -1.78M | n/a | -1.37M |
Operating Cash Flow | -4.18M | -4.18M | -8.11M | n/a | -4.49M | n/a | -10.11M | n/a | -5.16M | -256K | -8.67M | -10M | -7.33M |
Capital Expenditures | n/a | n/a | 278.00 | n/a | -5.72K | -4K | -2.43K | -5K | -4.88K | -89K | -2.56K | -10.47K | -2.49K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -1K | n/a | 1K | n/a | -29.15K | n/a | n/a | n/a | 2.56K | n/a | n/a |
Investing Cash Flow | n/a | n/a | -722 | n/a | -1K | -4K | -26.58K | -5K | -4.88K | -89K | -2.56K | -10.47K | -2.49K |
Debt Repayment | n/a | n/a | -10.37K | n/a | n/a | n/a | -32.15K | n/a | -27.77K | -34.51K | -23.75K | -58.29K | -24.25K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 369.32K | 149.16K | -72.02K | -673K | -156K | -17K | 13.56K | -57K | -80.97K | 5.47K | -245.25K | -2.49M | 34.19M |
Financial Cash Flow | 369.32K | 149.16K | 12.29K | 8.25M | 970K | -17K | -12.76K | 125K | -108.9K | -29K | -23K | 36.65M | 34.17M |
Net Cash Flow | -4.75M | n/a | 318.46K | 5.98M | -4.39M | 936K | -25.34M | -3.41M | -6.51M | 2.17M | -4.33M | 28.08M | 25.85M |
Free Cash Flow | -4.18M | -4.18M | -8.11M | -2.58M | -4.86M | 545K | -6.2M | -3.91M | -5.16M | -345K | -8.67M | -17.33M | -7.33M |